KGK Science Inc.
Mal Evans is an Adjunct Professor at Western University since July 2023. With a background in Animal Physiology and Endocrinology, they have held various research and teaching positions at University of Guelph, University of Western Ontario, and Dept. of Physical Medicine and Rehabilitation. Currently, Mal serves as the Chief Scientific Officer at KGK Science Inc., overseeing strategic clinical research projects related to health and wellness. As a Scientific Director, they led research in the nutraceutical space and provided guidance for the nutrition industry. Specializing in Evidence-Based Research, Mal has a wealth of experience in guiding research teams and developing new research designs to better understand dietary supplements.
This person is not in the org chart
KGK Science Inc.
Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies. From clinical study design to impactful product marketing, KGK has client success down to a science. At our state-of-the-art clinical research facilities, clinical staff, researchers, and regulatory experts quickly turn requests into results. We’ve guided hundreds of companies in taking their initial product concepts on to clinically proven claims and beyond, working to differentiate ideas and offer unique pathways through complex regulatory bodies including Health Canada, FDA, and FTC. Recognized globally as thought-leaders in cannabinoid science and regulation for the natural health product industry, KGK Science is proudly the first CRO in Canada to possess a Cannabis Research License, extending our 22 years of industry experience to include cannabis and hemp-derived products. As the leading CRO in the cannabis industry, KGK is focused on expertly conducting clinical trials and providing regulatory support to help bring innovative new health products to market, continuing to further global research and unlock the true value of the cannabis industry for clients and consumers.